Skip to main content
Clinical Trials/ISRCTN17940603
ISRCTN17940603
Active, not recruiting
未知

on-invasive diagnosis of urothelial carcinoma with urinary biomarkers and imaging after macroscopic haematuria

Västra Götaland Regional Council0 sites1,516 target enrollmentSeptember 4, 2020

Overview

Phase
未知
Intervention
Not specified
Conditions
Diagnostic workup in patients with macroscopic haematuria
Sponsor
Västra Götaland Regional Council
Enrollment
1516
Status
Active, not recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 4, 2020
End Date
January 1, 2024
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Västra Götaland Regional Council

Eligibility Criteria

Inclusion Criteria

  • 1\. Aged \=50 years
  • 2\. Referred to participating centres for evaluation of macroscopic haematuria according to standardised care pathway
  • 3\. Able to give signed informed consent

Exclusion Criteria

  • 1\. History of urothelial carcinoma
  • 2\. Unable to give voided urine sample/has urine catheter

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Not Applicable
Detection of bladder cancer using a fluorescent dye (PVP-Hypericin)Suspected non-muscle invasive (superficial) bladder cancerMedDRA version: 17.0Level: PTClassification code 10005003Term: Bladder cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Diagnosis [E01]
EUCTR2011-001819-30-DESanochemia Pharmazeutika AG220
Active, not recruiting
Not Applicable
Detection of bladder cancer using a fluorescent dye (PVP-Hypericin)Suspected non-muscle invasive (superficial) bladder cancerMedDRA version: 17.0Level: PTClassification code 10005003Term: Bladder cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Diagnosis [E01]
EUCTR2011-001819-30-ATSanochemia Pharmazeutika AG220
Completed
Phase 2
Detection of non-muscle invasive bladder cancer using PVP-Hypericin (Vidon®) fluorescence cystoscopy(Hypericin PDD)C67Malignant neoplasm of bladder
DRKS00003324Sanochemia Pharmazeutika AG227
Not yet recruiting
Not Applicable
Sentinel node biopsy for bladder cancer using the hybrid tracerBladder cancerBladder carcinoma10004994
NL-OMON41181eids Universitair Medisch Centrum30
Not yet recruiting
Not Applicable
Staging in urothelial carcinoma by using optical coherence tomographyrothelial carcinoma
JPRN-UMIN000017549Dept. of Urology, The University of Tokyo15